社区动脉粥样硬化风险研究中循环铜蓝蛋白、铜蓝蛋白相关基因与静脉血栓栓塞发生率
在社区动脉粥样硬化风险研究中,9933名53-75岁无静脉血栓栓塞的受试者于1996-1998年入组并随访至2011年。平均随访10.5年发生376例静脉血栓栓塞,校正传统危险因素和生物标志物后,循环铜蓝蛋白较高者静脉血栓栓塞发生率更高(风险比1.82,95%置信区间1.12-2.95),但铜蓝蛋白相关基因多态性与静脉血栓栓塞风险无关。
要点
- 循环铜蓝蛋白较高与静脉血栓栓塞发生率升高相关(风险比1.82,95%置信区间1.12-2.95)。
- rs11708215和rs13072552与铜蓝蛋白浓度相关,但与静脉血栓栓塞风险无关。
- 结果提示循环铜蓝蛋白可能并非静脉血栓栓塞风险的因果性生物标志物。
核心结论
- 高铜蓝蛋白浓度与静脉血栓栓塞风险升高相关,但铜蓝蛋白相关基因变异与静脉血栓栓塞风险升高无关。
- 作者认为循环铜蓝蛋白浓度可能与静脉血栓栓塞发生风险无因果关联。
研究设计与样本
- 观察性研究,纳入社区动脉粥样硬化风险研究中9933名53-75岁、无现患静脉血栓栓塞的男性和女性,1996-1998年入组,随访至2011年。
- 循环铜蓝蛋白在1996-1998年采集的储存血样中测定;rs11708215和rs13072552在8439名参与者中测定。
- 静脉血栓栓塞通过出院诊断代码识别,并经医生复核病历和影像报告验证。
主要发现
- 平均随访10.5年期间识别出376例静脉血栓栓塞。
- 校正传统危险因素和生物标志物后,循环铜蓝蛋白浓度较高与静脉血栓栓塞发生率较高相关(风险比1.82,95%置信区间1.12-2.95,比较第87.5-100百分位与最低四分位)。
- rs11708215和rs13072552均与铜蓝蛋白浓度相关,但与静脉血栓栓塞风险无关。
关键数值与推荐
- 循环铜蓝蛋白最高第87.5-100百分位相较于最低四分位的静脉血栓栓塞风险比1.82(95%置信区间1.12-2.95)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Essentials Ceruloplasmin (CP) is an acute-phase reactant and a potential biomarker of atherothrombotic risk. We assessed associations between CP and venous thromboembolism (VTE) risk in 9933 individuals. Higher circulating CP but not CP-related genes were associated with greater incident VTE rates. Circulating CP could be considered a non-causal biomarker of VTE risk in the community. SUMMARY: Background Ceruloplasmin (CP) is an acute-phase reactant and a potential biomarker of atherothrombotic risk. We assessed the associations between CP, CP-associated genetic variants and incident venous thomboembolism (VTE) in the Atherosclerosis Risk in Communities study. Methods and results In an observational study, 9933 men and women aged 53-75 years without prevalent VTE were included in 1996-1998 and followed through 2011. Circulating CP was measured in stored blood samples obtained in 1996-1998. Polymorphisms rs11708215 and rs13072552, which have been previously associated with CP concentrations, were measured in 8439 participants. VTEs were identified from hospital discharge codes and validated by physician review of medical records and imaging reports. Over a mean of 10.5 years of follow-up, 376 cases of VTE were identified. The association between circulating CP, CP-associated polymorphisms and the incidence of VTE was estimated. After adjustment for traditional risk factors and biomarkers, higher concentrations of circulating CP were associated with greater incident VTE rates (hazard ratio 1.82, 95% confidence interval 1.12-2.95, comparing the 87.5-100th percentile with the bottom quartile). Both rs11708215 and rs13072552 were associated with CP concentrations but not with VTE risk. Conclusions Even though high CP concentrations were associated with an increased VTE risk, CP-associated genetic variants were not associated with a higher risk of VTE. Our results suggest that circulating CP concentrations may not be causally related to the risk of incident VTE.
引用
- Arenas de Larriva AP, Alonso A, Norby FL, et al. Circulating ceruloplasmin, ceruloplasmin-associated genes and the incidence of venous thromboembolism in the Atherosclerosis Risk in Communities study. J Thromb Haemost. 2019. PMID: 30803124. doi:10.1111/jth.14420
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。